AC Immune SA Files 6-K Report
Ticker: ACIU · Form: 6-K · Filed: Aug 5, 2025 · CIK: 1651625
| Field | Detail |
|---|---|
| Company | Ac Immune SA (ACIU) |
| Form Type | 6-K |
| Filed Date | Aug 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, foreign-private-issuer
Related Tickers: ACIU
TL;DR
AC Immune SA filed a 6-K for June 30, 2025, mostly boilerplate for SEC compliance.
AI Summary
AC Immune SA filed a Form 6-K on August 5, 2025, reporting for the period ending June 30, 2025. The filing is a report of a foreign private issuer and is incorporated by reference into several of AC Immune SA's registration statements on Form F-3 and Form S-8.
Why It Matters
This filing provides routine updates for AC Immune SA as a foreign private issuer, ensuring compliance with SEC reporting requirements and keeping its registration statements current.
Risk Assessment
Risk Level: low — This is a routine 6-K filing for a foreign private issuer, containing standard disclosures and incorporation by reference, with no new material events disclosed.
Key Players & Entities
- AC Immune SA (company) — Registrant
- 0001558370-25-010174 (filing_id) — Accession Number
- 20250805 (date) — Filing Date
- 20250630 (date) — Period of Report
- Form 6-K (document_type) — Report Type
- EPFL Innovation Park Building B 1015 Lausanne, Switzerland (address) — Principal Executive Offices
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, providing information for the month of August 2025 and reporting for the period ending June 30, 2025.
Which registration statements will this filing be incorporated into?
This Report on Form 6-K shall be deemed to be incorporated by reference into the registration statements on Form F-3 (File Nos. 333-227016, 333-249655 and 333-277940) and Form S-8 (File Nos. 333-213865, 333-216539 and 333-233019) of AC Immune SA.
What is the filing date of this report?
The filing date of this report is August 5, 2025.
What period does this report cover?
This report is conformed for the period of report ending June 30, 2025.
Where are AC Immune SA's principal executive offices located?
AC Immune SA's principal executive offices are located at EPFL Innovation Park Building B, 1015 Lausanne, Switzerland.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on August 5, 2025 regarding AC Immune SA (ACIU).